$0.3180
-0.0736-18.79%
Last update: May 11, 4:00 PM
HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. (HEPA) Stock Price, Quote, News & History
HEPAOTCQB
Hepion Pharmaceuticals announces merger with Pharma Two B Ltd., creating a combined company focused on Parkinson's disease treatment. The merger values Hepion...
You can purchase shares of HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. (OTCQB:HEPA) through any online brokerage.
There are no as such competitors for HEPION PHARMS INC by Hepion Pharmaceuticals, Inc..
There is no analysis for HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. to provide a consensus price target.
The stock price for HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. (OTCQB: HEPA) is $0.0729 last updated May 11, 2026 at 4:00 PM EDT.
There are no upcoming dividends for HEPION PHARMS INC by Hepion Pharmaceuticals, Inc..
HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for HEPION PHARMS INC by Hepion Pharmaceuticals, Inc..
HEPION PHARMS INC by Hepion Pharmaceuticals, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development of drug therapy for the treatment of chronic liver diseases. The company is pioneering early cancer detection solutions with a novel liquid biopsy. diagnostics....
